{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T02:08:37Z","timestamp":1791252517664,"version":"4.1.0"},"reference-count":134,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2007,7,1]],"date-time":"2007-07-01T00:00:00Z","timestamp":1183248000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biochemical Pharmacology"],"published-print":{"date-parts":[[2007,7]]},"DOI":"10.1016\/j.bcp.2007.01.036","type":"journal-article","created":{"date-parts":[[2007,2,5]],"date-time":"2007-02-05T12:27:05Z","timestamp":1170678425000},"page":"177-190","source":"Crossref","is-referenced-by-count":230,"title":["Norepinephrine: The redheaded stepchild of Parkinson's disease"],"prefix":"10.1016","volume":"74","author":[{"given":"K.S.","family":"Rommelfanger","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Weinshenker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.bcp.2007.01.036_bib1","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1016\/S1474-4422(06)70471-9","article-title":"Epidemiology of Parkinson's disease","volume":"5","author":"de Lau","year":"2006","journal-title":"Lancet Neurol"},{"issue":"5","key":"10.1016\/j.bcp.2007.01.036_bib2","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1002\/ana.410320510","article-title":"Disease-specific patterns of locus coeruleus cell loss","volume":"32","author":"German","year":"1992","journal-title":"Ann Neurol"},{"issue":"1","key":"10.1016\/j.bcp.2007.01.036_bib3","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/j.1365-2990.1983.tb00320.x","article-title":"Pathological basis for neurotransmitter changes in Parkinson's disease","volume":"9","author":"Mann","year":"1983","journal-title":"Neuropathol Appl Neurobiol"},{"issue":"1","key":"10.1016\/j.bcp.2007.01.036_bib4","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.brainresrev.2004.02.002","article-title":"Noradrenergic mechanisms in neurodegenerative diseases: a theory","volume":"45","author":"Marien","year":"2004","journal-title":"Brain Res Brain Res Rev"},{"issue":"10","key":"10.1016\/j.bcp.2007.01.036_bib5","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1038\/nrd2087","article-title":"Novel pharmacological targets for the treatment of Parkinson's disease","volume":"5","author":"Schapira","year":"2006","journal-title":"Nat Rev Drug Discov"},{"issue":"3","key":"10.1016\/j.bcp.2007.01.036_bib6","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/0014-2999(93)90489-5","article-title":"Noradrenaline depletion exacerbates MPTP-induced striatal dopamine loss in mice","volume":"236","author":"Marien","year":"1993","journal-title":"Eur J Pharmacol"},{"issue":"2\u20133","key":"10.1016\/j.bcp.2007.01.036_bib7","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/0306-4522(91)90345-O","article-title":"Effects of locus coeruleus lesions on parkinsonian signs, striatal dopamine and substantia nigra cell loss after 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in monkeys: a possible role for the locus coeruleus in the progression of Parkinson's disease","volume":"41","author":"Mavridis","year":"1991","journal-title":"Neuroscience"},{"issue":"12","key":"10.1016\/j.bcp.2007.01.036_bib8","doi-asserted-by":"crossref","first-page":"2586","DOI":"10.1046\/j.1460-9568.2003.02684.x","article-title":"Potentiation of parkinsonian symptoms by depletion of locus coeruleus noradrenaline in 6-hydroxydopamine-induced partial degeneration of substantia nigra in rats","volume":"17","author":"Srinivasan","year":"2003","journal-title":"Eur J Neurosci"},{"key":"10.1016\/j.bcp.2007.01.036_bib9","first-page":"600","article-title":"Similarities and differences between MPTP-induced parkinsonsim and Parkinson's disease. Neuropathologic considerations","volume":"60","author":"Forno","year":"1993","journal-title":"Adv Neurol"},{"issue":"2","key":"10.1016\/j.bcp.2007.01.036_bib10","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/S0197-4580(02)00065-9","article-title":"Staging of brain pathology related to sporadic Parkinson's disease","volume":"24","author":"Braak","year":"2003","journal-title":"Neurobiol Aging"},{"issue":"2","key":"10.1016\/j.bcp.2007.01.036_bib11","first-page":"519","article-title":"Locus coeruleus and norepinephrine in Parkinson's disease","volume":"45","author":"Chan-Palay","year":"1991","journal-title":"Jpn J Psychiatry Neurol"},{"issue":"5","key":"10.1016\/j.bcp.2007.01.036_bib12","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1093\/jnen\/61.5.413","article-title":"Where does parkinson disease pathology begin in the brain?","volume":"61","author":"Del Tredici","year":"2002","journal-title":"J Neuropathol Exp Neurol"},{"issue":"6","key":"10.1016\/j.bcp.2007.01.036_bib13","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1111\/j.1365-2990.1993.tb00480.x","article-title":"A Golgi study of human locus coeruleus in normal brains and in Parkinson's disease","volume":"19","author":"Patt","year":"1993","journal-title":"Neuropathol Appl Neurobiol"},{"issue":"3","key":"10.1016\/j.bcp.2007.01.036_bib14","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1001\/archneur.60.3.337","article-title":"Neuronal loss is greater in the locus coeruleus than nucleus basalis and substantia nigra in Alzheimer and Parkinson diseases","volume":"60","author":"Zarow","year":"2003","journal-title":"Arch Neurol"},{"issue":"3","key":"10.1016\/j.bcp.2007.01.036_bib15","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/S1474-4422(06)70373-8","article-title":"Non-motor symptoms of Parkinson's disease: diagnosis and management","volume":"5","author":"Chaudhuri","year":"2006","journal-title":"Lancet Neurol"},{"issue":"5","key":"10.1016\/j.bcp.2007.01.036_bib16","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/j.clineuro.2005.08.002","article-title":"The effect of depression on motor function and disease severity of Parkinson's disease","volume":"108","author":"Papapetropoulos","year":"2006","journal-title":"Clin Neurol Neurosurg"},{"issue":"1","key":"10.1016\/j.bcp.2007.01.036_bib17","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.genhosppsych.2005.07.005","article-title":"Response to 4-month treatment with reboxetine in Parkinson's disease patients with a major depressive episode","volume":"28","author":"Pintor","year":"2006","journal-title":"Gen Hosp Psychiatry"},{"issue":"4","key":"10.1016\/j.bcp.2007.01.036_bib18","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1002\/mds.1143","article-title":"Idazoxan, an alpha-2 antagonist, and l-DOPA-induced dyskinesias in patients with Parkinson's disease","volume":"16","author":"Rascol","year":"2001","journal-title":"Mov Disord"},{"issue":"2","key":"10.1016\/j.bcp.2007.01.036_bib19","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1007\/s00702-002-0777-5","article-title":"An antihypokinesic action of alpha2-adrenoceptors upon MPTP-induced behaviour deficits in mice","volume":"110","author":"Archer","year":"2003","journal-title":"J Neural Transm"},{"issue":"2","key":"10.1016\/j.bcp.2007.01.036_bib20","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1007\/s002109900167","article-title":"Noradrenoceptor antagonism with idazoxan improves l-DOPA-induced dyskinesias in MPTP monkeys","volume":"361","author":"Grondin","year":"2000","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"10.1016\/j.bcp.2007.01.036_bib21","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1146\/annurev.bi.40.070171.002341","article-title":"Biochemistry of catecholamines","volume":"40","author":"Molinoff","year":"1971","journal-title":"Annu Rev Biochem"},{"issue":"1","key":"10.1016\/j.bcp.2007.01.036_bib22","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/0014-2999(93)90351-H","article-title":"Prazosin modulates the firing pattern of dopamine neurons in rat ventral tegmental area","volume":"233","author":"Grenhoff","year":"1993","journal-title":"Eur J Pharmacol"},{"issue":"1","key":"10.1016\/j.bcp.2007.01.036_bib23","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/0006-8993(74)91016-6","article-title":"Effects of lesions of locus coeruleus on regional distribution of dopamine-beta-hydroxylase activity in rat brain.","volume":"73","author":"Ross","year":"1974","journal-title":"Brain Res"},{"key":"10.1016\/j.bcp.2007.01.036_bib24","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1111\/j.1471-4159.1959.tb13216.x","article-title":"Localization of dopamine-beta-oxidase in brain","volume":"4","author":"Udenfriend","year":"1959","journal-title":"J Neurochem"},{"issue":"8","key":"10.1016\/j.bcp.2007.01.036_bib25","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1111\/j.1471-4159.1966.tb09873.x","article-title":"Regional studies of catecholamines in the rat brain. I. The disposition of [3H]norepinephrine, [3H]dopamine and [3H]dopa in various regions of the brain","volume":"13","author":"Glowinski","year":"1966","journal-title":"J Neurochem"},{"issue":"4","key":"10.1016\/j.bcp.2007.01.036_bib26","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1002\/syn.20023","article-title":"Ultrastructural interactions between terminals expressing the norepinephrine transporter and dopamine neurons in the rat and monkey ventral tegmental area","volume":"52","author":"Liprando","year":"2004","journal-title":"Synapse"},{"issue":"1\u20132","key":"10.1016\/j.bcp.2007.01.036_bib27","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.jneumeth.2004.04.040","article-title":"Quantification and pharmacological characterization of dialysate levels of noradrenaline in the striatum of freely-moving rats: release from adrenergic terminals and modulation by alpha2-autoreceptors","volume":"140","author":"Gobert","year":"2004","journal-title":"J Neurosci Meth"},{"issue":"2\u20133","key":"10.1016\/j.bcp.2007.01.036_bib28","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/S0014-2999(97)01375-7","article-title":"Alpha2-adrenergic control of dopamine overflow and metabolism in mouse striatum","volume":"339","author":"Yavich","year":"1997","journal-title":"Eur J Pharmacol"},{"issue":"1\u20133","key":"10.1016\/j.bcp.2007.01.036_bib29","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/S0014-2999(03)01324-4","article-title":"Atipamezole, an alpha2-adrenoceptor antagonist, augments the effects of l-DOPA on evoked dopamine release in rat striatum","volume":"462","author":"Yavich","year":"2003","journal-title":"Eur J Pharmacol"},{"issue":"1","key":"10.1016\/j.bcp.2007.01.036_bib30","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/0006-8993(90)91646-X","article-title":"Effects of locus coeruleus lesions on the release of endogenous dopamine in the rat nucleus accumbens and caudate nucleus as determined by intracerebral microdialysis.","volume":"523","author":"Lategan","year":"1990","journal-title":"Brain Res"},{"issue":"14","key":"10.1016\/j.bcp.2007.01.036_bib31","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1016\/0024-3205(92)90093-5","article-title":"Suppression of nigrostriatal and mesolimbic dopamine release in vivo following noradrenaline depletion by DSP-4: a microdialysis study","volume":"50","author":"Lategan","year":"1992","journal-title":"Life Sci"},{"issue":"2","key":"10.1016\/j.bcp.2007.01.036_bib32","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/S0006-8993(03)02677-5","article-title":"Effect of denervation of the locus coeruleus projections by DSP-4 treatment on [3H]-raclopride binding to dopamine D(2) receptors and D(2) receptor-G protein interaction in the rat striatum","volume":"976","author":"Harro","year":"2003","journal-title":"Brain Res"},{"issue":"10","key":"10.1016\/j.bcp.2007.01.036_bib33","doi-asserted-by":"crossref","first-page":"2221","DOI":"10.1038\/sj.npp.1301000","article-title":"Dopamine beta-hydroxylase knockout mice have alterations in dopamine signaling and are hypersensitive to cocaine","volume":"31","author":"Schank","year":"2006","journal-title":"Neuropsychopharmacology"},{"issue":"3\u20134","key":"10.1016\/j.bcp.2007.01.036_bib34","first-page":"193","article-title":"Noradrenaline loss selectivity exacerbates nigrostriatal toxicity in different species of rodents","volume":"12","author":"Fornai","year":"1997","journal-title":"Funct Neurol"},{"issue":"2","key":"10.1016\/j.bcp.2007.01.036_bib35","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1002\/(SICI)1098-2396(199810)30:2<205::AID-SYN10>3.0.CO;2-0","article-title":"Reduced MPTP neurotoxicity in striatum of the mutant mouse tottering","volume":"30","author":"Kilbourn","year":"1998","journal-title":"Synapse"},{"issue":"5","key":"10.1016\/j.bcp.2007.01.036_bib36","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1111\/j.1471-4159.2004.02785.x","article-title":"Reduced MPTP toxicity in noradrenaline transporter knockout mice","volume":"91","author":"Rommelfanger","year":"2004","journal-title":"J Neurochem"},{"key":"10.1016\/j.bcp.2007.01.036_bib37","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1146\/annurev.pharmtox.38.1.351","article-title":"Insights from in vivo modification of adrenergic receptor gene expression","volume":"38","author":"Rohrer","year":"1998","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"10.1016\/j.bcp.2007.01.036_bib38","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1111\/j.1749-6632.1999.tb09368.x","article-title":"Gene substitution\/knockout to delineate the role of alpha 2-adrenoceptor subtypes in mediating central effects of catecholamines and imidazolines","volume":"881","author":"Hein","year":"1999","journal-title":"Ann N Y Acad Sci"},{"issue":"2","key":"10.1016\/j.bcp.2007.01.036_bib39","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1046\/j.1471-4159.1995.65020704.x","article-title":"Clonidine suppresses 1-methyl-4-phenyl-1,2,3 6-tetrahydropyridine-induced reductions of striatal dopamine and tyrosine hydroxylase activity in mice","volume":"65","author":"Fornai","year":"1995","journal-title":"J Neurochem"},{"issue":"2","key":"10.1016\/j.bcp.2007.01.036_bib40","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/S0306-4522(02)00185-9","article-title":"Behavioral and neurochemical characterization of alpha(2A)-adrenergic receptor knockout mice","volume":"113","author":"Lahdesmaki","year":"2002","journal-title":"Neuroscience"},{"issue":"6","key":"10.1016\/j.bcp.2007.01.036_bib41","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/S0165-6147(97)01063-8","article-title":"Gene targeting \u2013 homing in on alpha 2-adrenoceptor-subtype function","volume":"18","author":"MacDonald","year":"1997","journal-title":"Trends Pharmacol Sci"},{"issue":"1","key":"10.1016\/j.bcp.2007.01.036_bib42","first-page":"48","article-title":"Targeted inactivation of the gene encoding the mouse alpha 2c-adrenoceptor homolog","volume":"48","author":"Link","year":"1995","journal-title":"Mol Pharmacol"},{"issue":"2","key":"10.1016\/j.bcp.2007.01.036_bib43","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1046\/j.1460-9568.1999.00464.x","article-title":"Role of alpha2C-adrenoceptor subtype in spatial working memory as revealed by mice with targeted disruption of the alpha2C-adrenoceptor gene","volume":"11","author":"Tanila","year":"1999","journal-title":"Eur J Neurosci"},{"issue":"1","key":"10.1016\/j.bcp.2007.01.036_bib44","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1124\/mol.51.1.36","article-title":"Genetic alteration of alpha 2C-adrenoceptor expression in mice: influence on locomotor, hypothermic, and neurochemical effects of dexmedetomidine, a subtype-nonselective alpha 2-adrenoceptor agonist","volume":"51","author":"Sallinen","year":"1997","journal-title":"Mol Pharmacol"},{"issue":"2","key":"10.1016\/j.bcp.2007.01.036_bib45","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/0006-8993(84)90117-3","article-title":"Adrenergic receptors in Parkinson's disease","volume":"322","author":"Cash","year":"1984","journal-title":"Brain Res"},{"issue":"6","key":"10.1016\/j.bcp.2007.01.036_bib46","doi-asserted-by":"crossref","first-page":"2350","DOI":"10.1046\/j.1471-4159.2000.0742350.x","article-title":"Spatiotemporal interaction of alpha(2) autoreceptors and noradrenaline transporters in the rat locus coeruleus: implications for volume transmission","volume":"74","author":"Callado","year":"2000","journal-title":"J Neurochem"},{"issue":"1\u20132","key":"10.1016\/j.bcp.2007.01.036_bib47","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/0006-8993(94)90012-4","article-title":"Volume transmission of dopamine over large distances may contribute to recovery from experimental parkinsonism","volume":"643","author":"Schneider","year":"1994","journal-title":"Brain Res"},{"issue":"3","key":"10.1016\/j.bcp.2007.01.036_bib48","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1016\/S0022-3565(24)38271-0","article-title":"Alpha2c adrenoceptors inhibit adenylyl cyclase in mouse striatum: potential activation by dopamine","volume":"289","author":"Zhang","year":"1999","journal-title":"J Pharmacol Exp Ther"},{"issue":"5","key":"10.1016\/j.bcp.2007.01.036_bib49","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/S0197-0186(02)00049-9","article-title":"Noradrenergic regulation of inflammatory gene expression in brain","volume":"41","author":"Feinstein","year":"2002","journal-title":"Neurochem Int"},{"issue":"12","key":"10.1016\/j.bcp.2007.01.036_bib50","first-page":"763","article-title":"Inflammation in the nervous system. Basic mechanisms and immunological concepts","volume":"147","author":"Lassmann","year":"1991","journal-title":"Rev Neurol (Paris)"},{"issue":"1","key":"10.1016\/j.bcp.2007.01.036_bib51","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1602\/neurorx.1.1.139","article-title":"Neurodegeneration and neuroprotection in Parkinson disease","volume":"1","author":"Fahn","year":"2004","journal-title":"NeuroRx"},{"issue":"3","key":"10.1016\/j.bcp.2007.01.036_bib52","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/S0197-4580(00)00124-X","article-title":"Inflammation and Alzheimer's disease","volume":"21","author":"Akiyama","year":"2000","journal-title":"Neurobiol Aging"},{"issue":"5","key":"10.1016\/j.bcp.2007.01.036_bib53","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1523\/JNEUROSCI.4236-05.2006","article-title":"Locus ceruleus degeneration promotes Alzheimer pathogenesis in amyloid precursor protein 23 transgenic mice","volume":"26","author":"Heneka","year":"2006","journal-title":"J Neurosci"},{"issue":"6","key":"10.1016\/j.bcp.2007.01.036_bib54","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1016\/S0361-9230(00)00291-4","article-title":"Catecholamines inhibit microglial nitric oxide production.","volume":"52","author":"Chang","year":"2000","journal-title":"Brain Res Bull"},{"issue":"6","key":"10.1016\/j.bcp.2007.01.036_bib55","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1016\/S0028-3908(02)00211-3","article-title":"Effects of norepinephrine on rat cultured microglial cells that express alpha1, alpha2, beta1 and beta2 adrenergic receptors","volume":"43","author":"Mori","year":"2002","journal-title":"Neuropharmacology"},{"issue":"7","key":"10.1016\/j.bcp.2007.01.036_bib56","doi-asserted-by":"crossref","first-page":"2434","DOI":"10.1523\/JNEUROSCI.22-07-02434.2002","article-title":"Noradrenergic depletion potentiates beta -amyloid-induced cortical inflammation: implications for Alzheimer's disease","volume":"22","author":"Heneka","year":"2002","journal-title":"J Neurosci"},{"issue":"2","key":"10.1016\/j.bcp.2007.01.036_bib57","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1086\/318198","article-title":"A quantitative-trait analysis of human plasma-dopamine beta-hydroxylase activity: evidence for a major functional polymorphism at the DBH locus","volume":"68","author":"Zabetian","year":"2001","journal-title":"Am J Hum Genet"},{"issue":"2","key":"10.1016\/j.bcp.2007.01.036_bib58","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1136\/jnnp.2005.075358","article-title":"Interaction between dopamine beta-hydroxylase and interleukin genes increases Alzheimer's disease risk","volume":"77","author":"Mateo","year":"2006","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"8","key":"10.1016\/j.bcp.2007.01.036_bib59","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1212\/WNL.38.8.1285","article-title":"Reactive microglia are positive for HLA-DR in the substantia nigra of Parkinson's and Alzheimer's disease brains","volume":"38","author":"McGeer","year":"1988","journal-title":"Neurology"},{"key":"10.1016\/j.bcp.2007.01.036_bib60","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1007\/978-3-211-45295-0_57","article-title":"Role of cytokines in inflammatory process in Parkinson's disease","volume":"70","author":"Sawada","year":"2006","journal-title":"J Neural Transm Suppl"},{"issue":"37","key":"10.1016\/j.bcp.2007.01.036_bib61","doi-asserted-by":"crossref","first-page":"9365","DOI":"10.1523\/JNEUROSCI.1504-06.2006","article-title":"Blocking soluble tumor necrosis factor signaling with dominant-negative tumor necrosis factor inhibitor attenuates loss of dopaminergic neurons in models of Parkinson's disease","volume":"26","author":"McCoy","year":"2006","journal-title":"J Neurosci"},{"issue":"6","key":"10.1016\/j.bcp.2007.01.036_bib62","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1096\/fj.05-5106com","article-title":"Deficiency of TNF receptors suppresses microglial activation and alters the susceptibility of brain regions to MPTP-induced neurotoxicity: role of TNF-alpha","volume":"20","author":"Sriram","year":"2006","journal-title":"Faseb J"},{"issue":"1","key":"10.1016\/j.bcp.2007.01.036_bib63","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1002\/cne.20098","article-title":"Inverse relationship between the contents of neuromelanin pigment and the vesicular monoamine transporter-2: human midbrain dopamine neurons","volume":"473","author":"Liang","year":"2004","journal-title":"J Comp Neurol"},{"issue":"22","key":"10.1016\/j.bcp.2007.01.036_bib64","doi-asserted-by":"crossref","first-page":"11869","DOI":"10.1073\/pnas.97.22.11869","article-title":"Neuromelanin biosynthesis is driven by excess cytosolic catecholamines not accumulated by synaptic vesicles","volume":"97","author":"Sulzer","year":"2000","journal-title":"Proc Natl Acad Sci USA"},{"issue":"5","key":"10.1016\/j.bcp.2007.01.036_bib65","doi-asserted-by":"crossref","first-page":"1973","DOI":"10.1046\/j.1471-4159.1998.70051973.x","article-title":"Increased MPTP neurotoxicity in vesicular monoamine transporter 2 heterozygote knockout mice","volume":"70","author":"Gainetdinov","year":"1998","journal-title":"J Neurochem"},{"issue":"1","key":"10.1016\/j.bcp.2007.01.036_bib66","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1006\/abbi.1993.1189","article-title":"Monoamine metabolism provides an antioxidant defense in the brain against oxidant- and free radical-induced damage","volume":"302","author":"Liu","year":"1993","journal-title":"Arch Biochem Biophys"},{"issue":"6","key":"10.1016\/j.bcp.2007.01.036_bib67","doi-asserted-by":"crossref","first-page":"1882","DOI":"10.1124\/mol.104.007864","article-title":"The neurotransmitter noradrenaline rescues septal cholinergic neurons in culture from degeneration caused by low-level oxidative stress","volume":"67","author":"Traver","year":"2005","journal-title":"Mol Pharmacol"},{"issue":"1","key":"10.1016\/j.bcp.2007.01.036_bib68","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1046\/j.1471-4159.2001.00556.x","article-title":"Noradrenaline provides long-term protection to dopaminergic neurons by reducing oxidative stress","volume":"79","author":"Troadec","year":"2001","journal-title":"J Neurochem"},{"issue":"2","key":"10.1016\/j.bcp.2007.01.036_bib69","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/S0006-8993(02)02889-5","article-title":"Regulation of norepinephrine transporter abundance by catecholamines and desipramine in vivo.","volume":"946","author":"Weinshenker","year":"2002","journal-title":"Brain Res"},{"issue":"3","key":"10.1016\/j.bcp.2007.01.036_bib70","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1002\/ana.20063","article-title":"A functional polymorphism regulating dopamine beta-hydroxylase influences against Parkinson's disease","volume":"55","author":"Healy","year":"2004","journal-title":"Ann Neurol"},{"issue":"5","key":"10.1016\/j.bcp.2007.01.036_bib71","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1016\/j.pnpbp.2004.05.034","article-title":"Noradrenaline storage function of species-specific protein bodies, markers of monoamine neurons in human locus coeruleus demonstrated by dopamine-beta-hydroxylase immunogold localization","volume":"28","author":"Issidorides","year":"2004","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"issue":"2","key":"10.1016\/j.bcp.2007.01.036_bib72","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1002\/(SICI)1096-9861(19980309)392:2<227::AID-CNE6>3.0.CO;2-4","article-title":"Galanin\/GMAP- and NPY-like immunoreactivities in locus coeruleus and noradrenergic nerve terminals in the hippocampal formation and cortex with notes on the galanin-R1 and -R2 receptors","volume":"392","author":"Xu","year":"1998","journal-title":"J Comp Neurol"},{"issue":"2","key":"10.1016\/j.bcp.2007.01.036_bib73","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1002\/cne.902920204","article-title":"Postnatal development of preproenkephalin mRNA containing neurons in the rat lower brainstem","volume":"292","author":"Morita","year":"1990","journal-title":"J Comp Neurol"},{"issue":"4","key":"10.1016\/j.bcp.2007.01.036_bib74","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1002\/(SICI)1098-2396(19990315)31:4<309::AID-SYN10>3.0.CO;2-6","article-title":"CART peptides colocalize with tyrosine hydroxylase neurons in rat locus coeruleus","volume":"31","author":"Koylu","year":"1999","journal-title":"Synapse"},{"issue":"1","key":"10.1016\/j.bcp.2007.01.036_bib75","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/0306-4522(94)00386-J","article-title":"Brain-derived neurotrophic factor messenger RNA is expressed in the septum, hypothalamus and in adrenergic brain stem nuclei of adult rat brain and is increased by osmotic stimulation in the paraventricular nucleus","volume":"64","author":"Castren","year":"1995","journal-title":"Neuroscience"},{"issue":"7","key":"10.1016\/j.bcp.2007.01.036_bib76","doi-asserted-by":"crossref","first-page":"2295","DOI":"10.1523\/JNEUROSCI.17-07-02295.1997","article-title":"Distribution of brain-derived neurotrophic factor (BDNF) protein and mRNA in the normal adult rat CNS: evidence for anterograde axonal transport","volume":"17","author":"Conner","year":"1997","journal-title":"J Neurosci"},{"issue":"24","key":"10.1016\/j.bcp.2007.01.036_bib77","doi-asserted-by":"crossref","first-page":"10700","DOI":"10.1523\/JNEUROSCI.18-24-10700.1998","article-title":"Differential regulation of neurotrophin and trk receptor mRNAs in catecholaminergic nuclei during chronic opiate treatment and withdrawal","volume":"18","author":"Numan","year":"1998","journal-title":"J Neurosci"},{"issue":"21","key":"10.1016\/j.bcp.2007.01.036_bib78","doi-asserted-by":"crossref","first-page":"11569","DOI":"10.1073\/pnas.210254597","article-title":"Galanin regulates the postnatal survival of a subset of basal forebrain cholinergic neurons","volume":"97","author":"O\u2019Meara","year":"2000","journal-title":"Proc Natl Acad Sci USA"},{"issue":"14","key":"10.1016\/j.bcp.2007.01.036_bib79","doi-asserted-by":"crossref","first-page":"5105","DOI":"10.1073\/pnas.0304823101","article-title":"Galanin acts as a neuroprotective factor to the hippocampus","volume":"101","author":"Elliott-Hunt","year":"2004","journal-title":"Proc Natl Acad Sci USA"},{"issue":"5","key":"10.1016\/j.bcp.2007.01.036_bib80","doi-asserted-by":"crossref","first-page":"2028","DOI":"10.1046\/j.1471-4159.1999.02028.x","article-title":"Preservation of noradrenergic neurons in the locus ceruleus that coexpress galanin mRNA in Alzheimer's disease","volume":"73","author":"Miller","year":"1999","journal-title":"J Neurochem"},{"issue":"2","key":"10.1016\/j.bcp.2007.01.036_bib81","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1111\/j.1750-3639.1997.tb01058.x","article-title":"A confocal microscopic analysis of galaninergic hyperinnervation of cholinergic basal forebrain neurons in Alzheimer's disease","volume":"7","author":"Bowser","year":"1997","journal-title":"Brain Pathol"},{"issue":"2","key":"10.1016\/j.bcp.2007.01.036_bib82","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.brainres.2005.05.072","article-title":"Comparison of the capability of GDNF, BDNF, or both, to protect nigrostriatal neurons in a rat model of Parkinson's disease","volume":"1052","author":"Sun","year":"2005","journal-title":"Brain Res"},{"issue":"8","key":"10.1016\/j.bcp.2007.01.036_bib83","doi-asserted-by":"crossref","first-page":"2808","DOI":"10.1523\/JNEUROSCI.18-08-02808.1998","article-title":"Functional evidence that BDNF is an anterograde neuronal trophic factor in the CNS","volume":"18","author":"Fawcett","year":"1998","journal-title":"J Neurosci"},{"issue":"3","key":"10.1016\/j.bcp.2007.01.036_bib84","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1002\/(SICI)1096-9861(19991025)413:3<449::AID-CNE7>3.0.CO;2-2","article-title":"Characterization of dopaminergic midbrain neurons in a DBH:BDNF transgenic mouse","volume":"413","author":"Alonso-Vanegas","year":"1999","journal-title":"J Comp Neurol"},{"issue":"1","key":"10.1016\/j.bcp.2007.01.036_bib85","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.neuron.2006.09.026","article-title":"Mechanisms of Parkinson's disease linked to pathological alpha-synuclein: new targets for drug discovery","volume":"52","author":"Lee","year":"2006","journal-title":"Neuron"},{"issue":"5321","key":"10.1016\/j.bcp.2007.01.036_bib86","doi-asserted-by":"crossref","first-page":"2045","DOI":"10.1126\/science.276.5321.2045","article-title":"Mutation in the alpha-synuclein gene identified in families with Parkinson's disease","volume":"276","author":"Polymeropoulos","year":"1997","journal-title":"Science"},{"issue":"6645","key":"10.1016\/j.bcp.2007.01.036_bib87","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1038\/42166","article-title":"Alpha-synuclein in Lewy bodies","volume":"388","author":"Spillantini","year":"1997","journal-title":"Nature"},{"issue":"3","key":"10.1016\/j.bcp.2007.01.036_bib88","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1111\/j.1471-4159.2006.04098.x","article-title":"Abnormal compartmentalization of norepinephrine in mouse dentate gyrus in alpha-synuclein knockout and A30P transgenic mice","volume":"99","author":"Yavich","year":"2006","journal-title":"J Neurochem"},{"issue":"29","key":"10.1016\/j.bcp.2007.01.036_bib89","doi-asserted-by":"crossref","first-page":"10744","DOI":"10.1073\/pnas.0401297101","article-title":"Loss of locus coeruleus neurons and reduced startle in parkin null mice","volume":"101","author":"Von Coelln","year":"2004","journal-title":"Proc Natl Acad Sci USA"},{"issue":"3","key":"10.1016\/j.bcp.2007.01.036_bib90","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/0024-3205(85)90059-1","article-title":"MPTP neurotoxicity: an overview and characterization of phases of toxicity","volume":"36","author":"Langston","year":"1985","journal-title":"Life Sci"},{"issue":"1","key":"10.1016\/j.bcp.2007.01.036_bib91","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/0006-8993(90)91055-L","article-title":"Dose-dependent destruction of the coeruleus-cortical and nigral-striatal projections by MPTP","volume":"527","author":"Seniuk","year":"1990","journal-title":"Brain Res"},{"issue":"1","key":"10.1016\/j.bcp.2007.01.036_bib92","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1006\/exnr.2002.8021","article-title":"Detection of behavioral impairments correlated to neurochemical deficits in mice treated with moderate doses of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine","volume":"178","author":"Tillerson","year":"2002","journal-title":"Exp Neurol"},{"issue":"1","key":"10.1016\/j.bcp.2007.01.036_bib93","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/S0022-3565(24)37011-9","article-title":"Effects of noradrenergic lesions on MPTP\/MPP+ kinetics and MPTP-induced nigrostriatal dopamine depletions","volume":"283","author":"Fornai","year":"1997","journal-title":"J Pharmacol Exp Ther"},{"issue":"9","key":"10.1016\/j.bcp.2007.01.036_bib94","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1007\/s00702-005-0402-5","article-title":"Influence of noradrenaline denervation on MPTP-induced deficits in mice","volume":"113","author":"Archer","year":"2006","journal-title":"J Neural Transm"},{"issue":"4","key":"10.1016\/j.bcp.2007.01.036_bib95","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1016\/S0306-4522(00)00385-7","article-title":"Pharmacological inactivation of the vesicular monoamine transporter can enhance 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced neurodegeneration of midbrain dopaminergic neurons, but not locus coeruleus noradrenergic neurons","volume":"101","author":"German","year":"2000","journal-title":"Neuroscience"},{"issue":"9","key":"10.1016\/j.bcp.2007.01.036_bib96","doi-asserted-by":"crossref","first-page":"3413","DOI":"10.1073\/pnas.0409713102","article-title":"Parkinson-like syndrome induced by continuous MPTP infusion: convergent roles of the ubiquitin-proteasome system and alpha-synuclein","volume":"102","author":"Fornai","year":"2005","journal-title":"Proc Natl Acad Sci USA"},{"issue":"6523","key":"10.1016\/j.bcp.2007.01.036_bib97","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1038\/374643a0","article-title":"Noradrenaline is essential for mouse fetal development","volume":"374","author":"Thomas","year":"1995","journal-title":"Nature"},{"issue":"3","key":"10.1016\/j.bcp.2007.01.036_bib98","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1002\/cne.20263","article-title":"Postnatal development of the cerebellum and the CNS adrenergic system is independent of norepinephrine and epinephrine","volume":"477","author":"Jin","year":"2004","journal-title":"J Comp Neurol"},{"issue":"6","key":"10.1016\/j.bcp.2007.01.036_bib99","doi-asserted-by":"crossref","first-page":"2468","DOI":"10.1046\/j.1471-4159.1998.70062468.x","article-title":"Restoration of norepinephrine and reversal of phenotypes in mice lacking dopamine beta-hydroxylase","volume":"70","author":"Thomas","year":"1998","journal-title":"J Neurochem"},{"issue":"2","key":"10.1016\/j.bcp.2007.01.036_bib100","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/S0969-9961(03)00108-6","article-title":"Behavioral changes are not directly related to striatal monoamine levels, number of nigral neurons, or dose of parkinsonian toxin MPTP in mice","volume":"14","author":"Rousselet","year":"2003","journal-title":"Neurobiol Dis"},{"issue":"1","key":"10.1016\/j.bcp.2007.01.036_bib101","first-page":"93","article-title":"Alterations of the central noradrenergic system in MPTP-induced monkey parkinsonism","volume":"62","author":"Miyoshi","year":"1988","journal-title":"Res Commun Chem Pathol Pharmacol"},{"issue":"4","key":"10.1016\/j.bcp.2007.01.036_bib102","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1002\/ana.410200403","article-title":"Locus ceruleus lesions and eosinophilic inclusions in MPTP-treated monkeys","volume":"20","author":"Forno","year":"1986","journal-title":"Ann Neurol"},{"issue":"1\u20132","key":"10.1016\/j.bcp.2007.01.036_bib103","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/0304-3940(85)90424-0","article-title":"Sites of the neurotoxic action of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in the macaque monkey include the ventral tegmental area and the locus coeruleus","volume":"61","author":"Mitchell","year":"1985","journal-title":"Neurosci Lett"},{"issue":"14","key":"10.1016\/j.bcp.2007.01.036_bib104","doi-asserted-by":"crossref","first-page":"4591","DOI":"10.1073\/pnas.81.14.4591","article-title":"Parkinsonism-inducing neurotoxin, N-methyl-4-phenyl-1,2,3,6 -tetrahydropyridine: characterization and localization of receptor binding sites in rat and human brain","volume":"81","author":"Javitch","year":"1984","journal-title":"Proc Natl Acad Sci USA"},{"issue":"7","key":"10.1016\/j.bcp.2007.01.036_bib105","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1016\/0092-8674(95)90145-0","article-title":"Dopamine-deficient mice are severely hypoactive, adipsic, and aphagic","volume":"83","author":"Zhou","year":"1995","journal-title":"Cell"},{"key":"10.1016\/j.bcp.2007.01.036_bib106","series-title":"2006 neuroscience meeting planner","article-title":"The alpha1-adrenoceptor antagonist prazosin attenuates the antiparkinsonian actions of l-DOPA in MPTP-treated macaques","author":"Visanji","year":"2006"},{"issue":"9","key":"10.1016\/j.bcp.2007.01.036_bib107","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1016\/0028-3908(87)90110-9","article-title":"Pharmacological characteristics of tremor, rigidity and hypokinesia induced by reserpine in rat","volume":"26","author":"Colpaert","year":"1987","journal-title":"Neuropharmacology"},{"issue":"2","key":"10.1016\/j.bcp.2007.01.036_bib108","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/0006-8993(91)90624-5","article-title":"Differential modulation of (+)-amphetamine-induced rotation in unilateral substantia nigra-lesioned rats by alpha 1 as compared to alpha 2 agonists and antagonists","volume":"562","author":"Mavridis","year":"1991","journal-title":"Brain Res"},{"issue":"2","key":"10.1016\/j.bcp.2007.01.036_bib109","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/0014-2999(76)90126-6","article-title":"The roles of noradrenaline and dopamine in contraversive circling behaviour seen after unilateral electrolytic lesions of the locus coeruleus","volume":"39","author":"Donaldson","year":"1976","journal-title":"Eur J Pharmacol"},{"issue":"Pt. 4","key":"10.1016\/j.bcp.2007.01.036_bib110","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1093\/brain\/awh102","article-title":"Presynaptic mechanisms of motor fluctuations in Parkinson's disease: a probabilistic model","volume":"127","author":"de la Fuente-Fernandez","year":"2004","journal-title":"Brain"},{"issue":"Pt 12","key":"10.1016\/j.bcp.2007.01.036_bib111","doi-asserted-by":"crossref","first-page":"2747","DOI":"10.1093\/brain\/awh290","article-title":"Levodopa-induced changes in synaptic dopamine levels increase with progression of Parkinson's disease: implications for dyskinesias","volume":"127","author":"de la Fuente-Fernandez","year":"2004","journal-title":"Brain"},{"issue":"6","key":"10.1016\/j.bcp.2007.01.036_bib112","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1177\/1073858403255839","article-title":"D1 dopamine receptor supersensitivity in the dopamine-depleted striatum animal model of Parkinson's disease","volume":"9","author":"Gerfen","year":"2003","journal-title":"Neuroscientist"},{"issue":"4","key":"10.1016\/j.bcp.2007.01.036_bib113","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1002\/mds.20394","article-title":"Striatal synaptic plasticity: implications for motor learning and Parkinson's disease","volume":"20","author":"Pisani","year":"2005","journal-title":"Mov Disord"},{"key":"10.1016\/j.bcp.2007.01.036_bib114","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1111\/j.1749-6632.2003.tb07477.x","article-title":"Pathophysiology of Parkinson's disease: the MPTP primate model of the human disorder","volume":"991","author":"Wichmann","year":"2003","journal-title":"Ann N Y Acad Sci"},{"issue":"6","key":"10.1016\/j.bcp.2007.01.036_bib115","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1097\/00002826-200311000-00008","article-title":"Noradrenergic drugs for levodopa-induced dyskinesia","volume":"26","author":"Colosimo","year":"2003","journal-title":"Clin Neuropharmacol"},{"issue":"8","key":"10.1016\/j.bcp.2007.01.036_bib116","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1002\/mds.10464","article-title":"Fipamezole (JP-1730) is a potent alpha2 adrenergic receptor antagonist that reduces levodopa-induced dyskinesia in the MPTP-lesioned primate model of Parkinson's disease","volume":"18","author":"Savola","year":"2003","journal-title":"Mov Disord"},{"issue":"6758","key":"10.1016\/j.bcp.2007.01.036_bib117","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1038\/46040","article-title":"Two functionally distinct alpha2-adrenergic receptors regulate sympathetic neurotransmission","volume":"402","author":"Hein","year":"1999","journal-title":"Nature"},{"issue":"1\u20132","key":"10.1016\/j.bcp.2007.01.036_bib118","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/0006-8993(94)90534-7","article-title":"Locus coeruleus lesions potentiate neurotoxic effects of MPTP in dopaminergic neurons of the substantia nigra","volume":"668","author":"Bing","year":"1994","journal-title":"Brain Res"},{"issue":"2","key":"10.1016\/j.bcp.2007.01.036_bib119","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1124\/jpet.106.106583","article-title":"Modafinil occupies dopamine and norepinephrine transporters in vivo and modulates the transporters and trace amine activity in vitro","volume":"319","author":"Madras","year":"2006","journal-title":"J Pharmacol Exp Ther"},{"issue":"5\u20136","key":"10.1016\/j.bcp.2007.01.036_bib120","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1097\/00008877-200609000-00011","article-title":"Neuroprotective effects of modafinil in a marmoset Parkinson model: behavioral and neurochemical aspects","volume":"17","author":"van Vliet","year":"2006","journal-title":"Behav Pharmacol"},{"issue":"4","key":"10.1016\/j.bcp.2007.01.036_bib121","doi-asserted-by":"crossref","first-page":"300","DOI":"10.4088\/JCP.v63n0405","article-title":"Effect of reboxetine on depression in Parkinson's disease patients","volume":"63","author":"Lemke","year":"2002","journal-title":"J Clin Psychiatry"},{"issue":"6","key":"10.1016\/j.bcp.2007.01.036_bib122","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1016\/j.neuropharm.2005.11.022","article-title":"Effect of the attention deficit\/hyperactivity disorder drug atomoxetine on extracellular concentrations of norepinephrine and dopamine in several brain regions of the rat","volume":"50","author":"Swanson","year":"2006","journal-title":"Neuropharmacology"},{"issue":"12","key":"10.1016\/j.bcp.2007.01.036_bib123","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1358\/dof.2004.029.12.855246","article-title":"Norepinephrine transporter inhibitors and their therapeutic potential","volume":"29","author":"Zhou","year":"2004","journal-title":"Drugs Future"},{"issue":"20","key":"10.1016\/j.bcp.2007.01.036_bib124","doi-asserted-by":"crossref","first-page":"2003","DOI":"10.1016\/0024-3205(88)90500-0","article-title":"Clonidine regularizes substantia nigra dopamine cell firing","volume":"42","author":"Grenhoff","year":"1988","journal-title":"Life Sci"},{"issue":"1","key":"10.1016\/j.bcp.2007.01.036_bib125","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1007\/BF01244934","article-title":"Noradrenergic modulation of midbrain dopamine cell firing elicited by stimulation of the locus coeruleus in the rat","volume":"93","author":"Grenhoff","year":"1993","journal-title":"J Neural Transm Gen Sect"},{"issue":"30","key":"10.1016\/j.bcp.2007.01.036_bib126","doi-asserted-by":"crossref","first-page":"3831","DOI":"10.2174\/138161206778559687","article-title":"PET imaging of norepinephrine transporters","volume":"12","author":"Ding","year":"2006","journal-title":"Curr Pharm Des"},{"issue":"2","key":"10.1016\/j.bcp.2007.01.036_bib127","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/0006-8993(92)90711-H","article-title":"Regional differences in the regulation of dopamine and noradrenaline release in medial frontal cortex, nucleus accumbens and caudate-putamen: a microdialysis study in the rat","volume":"581","author":"Cenci","year":"1992","journal-title":"Brain Res"},{"issue":"8","key":"10.1016\/j.bcp.2007.01.036_bib128","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1586\/14737175.6.8.1181","article-title":"Treatment of advanced Parkinson's disease","volume":"6","author":"Diamond","year":"2006","journal-title":"Expert Rev Neurother"},{"key":"10.1016\/j.bcp.2007.01.036_bib129","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/1750-1172-1-7","article-title":"Dopamine beta-hydroxylase deficiency","volume":"1","author":"Senard","year":"2006","journal-title":"Orphanet J Rare Dis"},{"issue":"1","key":"10.1016\/j.bcp.2007.01.036_bib130","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.jad.2003.08.001","article-title":"Reboxetine adjunct for partial or nonresponders to antidepressant treatment","volume":"81","author":"Rubio","year":"2004","journal-title":"J Affect Disord"},{"issue":"1","key":"10.1016\/j.bcp.2007.01.036_bib131","first-page":"60","article-title":"L-threo-DOPS therapy and parkinsonism","volume":"38","author":"Narabayashi","year":"1986","journal-title":"No To Shinkei"},{"issue":"1","key":"10.1016\/j.bcp.2007.01.036_bib132","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1007\/s00213-005-0139-8","article-title":"Effects of dopamine beta-hydroxylase genotype and disulfiram inhibition on catecholamine homeostasis in mice","volume":"183","author":"Bourdelat-Parks","year":"2005","journal-title":"Psychopharmacology (Berl)"},{"issue":"2","key":"10.1016\/j.bcp.2007.01.036_bib133","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1093\/schbul\/6.2.338","article-title":"Parents of high risk subjects defined by levels of monoamine oxidase activity","volume":"6","author":"Puchall","year":"1980","journal-title":"Schizophr Bull"},{"issue":"8","key":"10.1016\/j.bcp.2007.01.036_bib134","first-page":"2303","article-title":"Human pharmacogenetics of methyl conjugation","volume":"43","author":"Weinshilboum","year":"1984","journal-title":"Fed Proc"}],"container-title":["Biochemical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S000629520700086X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S000629520700086X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,13]],"date-time":"2025-01-13T09:50:19Z","timestamp":1736761819000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S000629520700086X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,7]]},"references-count":134,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2007,7]]}},"alternative-id":["S000629520700086X"],"URL":"https:\/\/doi.org\/10.1016\/j.bcp.2007.01.036","relation":{},"ISSN":["0006-2952"],"issn-type":[{"value":"0006-2952","type":"print"}],"subject":[],"published":{"date-parts":[[2007,7]]}}}